{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:20:28Z","timestamp":1793683228808,"version":"4.5.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"US Army, Department of Defense Medical Research and Development Program","award":["DM102881"],"award-info":[{"award-number":["DM102881"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.euroneuro.2013.11.007","type":"journal-article","created":{"date-parts":[[2013,11,23]],"date-time":"2013-11-23T12:45:39Z","timestamp":1385210739000},"page":"142-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model"],"prefix":"10.1016","volume":"24","author":[{"given":"L.I.","family":"Serova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Laukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Alaluf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pucillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.","family":"Sabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.11.007_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1517\/14728210902972494","article-title":"Posttraumatic stress disorder: emerging consepts of pharmacotherapy","volume":"14","author":"Baker","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/npp.2011.230","article-title":"The Neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder","volume":"37","author":"Cohen","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2012.09.004","article-title":"Neuropeptide Y and its role in CNS disease and repair","volume":"238","author":"Decressac","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib5","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2174\/156802607782341037","article-title":"Relevance of neuropeptide Y (NPY) in psychiatry","volume":"7","author":"Eaton","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib6","first-page":"105","article-title":"Cues to the usefullness of grooming behavior in the evaluation of anxiety in the elevated plus-maze","volume":"5","author":"Estanislau","year":"2012","journal-title":"Psychol. Behav."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.janxdis.2012.07.009","article-title":"Pharmacological treatment of anxiety disorders: current treatments and future directions","volume":"26","author":"Farach","year":"2012","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/npp.2011.317","article-title":"Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons","volume":"37","author":"Ionescu","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1682\/JRRD.2011.09.0183","article-title":"Pharmacotherapy for posttraumatic stress disorder: review with clinical applications","volume":"49","author":"Jeffreys","year":"2012","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib11","doi-asserted-by":"crossref","unstructured":"Jonas, D., Cusack, K., Forneris C.A. et al., 2013. Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD). Comparative Effectiveness Review no. 92. Agency for Healthcare Research and Quality, AHRQ Publication no. 13-EHC11-EF. Rockville, MD.","DOI":"10.1037\/e553842013-001"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneumeth.2004.10.001","article-title":"The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research","volume":"143","author":"Kalueff","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4530(97)00044-9","article-title":"Stress-restress: effects on ACTH and fast feedback","volume":"22","author":"Liberzon","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrn3339","article-title":"Biological studies of post-traumatic stress disorder","volume":"13","author":"Pitman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/mp.2012.101","article-title":"Neuropeptide y and posttraumatic stress disorder","volume":"18","author":"Sah","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbr.2013.05.006","article-title":"Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress","volume":"250C","author":"Serova","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuroscience.2013.01.040","article-title":"Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats","volume":"236","author":"Serova","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1152\/physrev.1992.72.3.825","article-title":"Ethology and neurobiology of grooming behavior","volume":"72","author":"Spruijt","year":"1992","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neulet.2008.06.031","article-title":"A modified single-prolonged stress model for post-traumatic stress disorder","volume":"441","author":"Wang","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2013.11.007_bib22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14728222.2011.628314","article-title":"Central functions of neuropeptide Y in mood and anxiety disorders","volume":"15","author":"Wu","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.euroneuro.2013.11.007_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJMra012941","article-title":"Post-traumatic stress disorder","volume":"346","author":"Yehuda","year":"2002","journal-title":"N. Engl. J. Med."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13003386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13003386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T21:04:51Z","timestamp":1564866291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13003386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0924977X13003386"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.11.007","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}